# Evaluate the Pharmacokinetics of Simvastatin When Coadministered With PEX168 in Healthy Adult Subjects

> **NCT02447601** · PHASE1 · COMPLETED · sponsor: **Jiangsu Hansoh Pharmaceutical Co., Ltd.** · enrollment: 16 (actual)

## Conditions studied

- Type 2 Diabetes Mellitus

## Interventions

- **DRUG:** PEX168
- **DRUG:** Simvastatin

## Key facts

- **NCT ID:** NCT02447601
- **Lead sponsor:** Jiangsu Hansoh Pharmaceutical Co., Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-03-30
- **Primary completion:** 2015-05-14
- **Final completion:** 2015-08-11
- **Target enrollment:** 16 (ACTUAL)
- **Last updated:** 2017-01-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02447601

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02447601, "Evaluate the Pharmacokinetics of Simvastatin When Coadministered With PEX168 in Healthy Adult Subjects". Retrieved via AI Analytics 2026-06-06 from https://api.ai-analytics.org/clinical/NCT02447601. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*